Thermo Fisher Scientific announced on October 27, 2026 that Executive Vice President Michael D. Shafer will retire effective December 31, 2026. The filing does not give a reason for the retirement or name a successor, so its effect on shareholders is not stated.
Michael D. Shafer, Executive Vice President, will retire effective December 31, 2026.
The Company announced the retirement on October 27, 2026.
The filing does not name a successor or describe any compensation arrangements.
Thermo Fisher reported third-quarter 2026 results for the period ended September 26, 2026, with revenue up 9% to $12.14 billion and GAAP diluted EPS up 9% to $4.64. Organic revenue growth was 6%, and the company said it would give updated 2026 guidance on its earnings call that morning, so shareholders will get the outlook only through that call and not in this filing.
Revenue $12.14 billion, up from $11.12 billion a year earlier; organic growth 6%
Thermo Fisher reported second-quarter 2026 results for the quarter ended June 27, with revenue up 10% to $11.99 billion, including 5% organic growth. GAAP diluted EPS rose 9% to $4.68 and adjusted EPS rose 13% to $6.03. The company said it will provide updated 2026 guidance on its earnings call that morning, so the new outlook is not in the filing.
Q2 revenue was $11.99 billion versus $10.85 billion a year earlier; organic growth was 5%.
GAAP operating income was $2.09 billion, up 14%, with operating margin at 17.4% versus 16.9%.
The company repurchased $1.0 billion of stock during the quarter and announced the divestiture of its microbiology business.
Thermo Fisher reported first-quarter 2026 results for the quarter ended March 28, 2026, with revenue up 6% to $11.01 billion and GAAP diluted EPS up 11% to $4.43. Organic revenue growth was 1%, and the company said it completed the Clario acquisition and repurchased $3.0 billion of stock during the quarter. The company said it will provide updated 2026 guidance on its earnings call, so the filing itself contains no new guidance.
Revenue grew 6% to $11.01 billion from $10.36 billion a year earlier; organic revenue growth was 1%.
GAAP diluted EPS was $4.43, up 11%; adjusted EPS was $5.44, up 6%.
GAAP operating margin was 16.9%, compared with 16.6%; adjusted operating margin was 21.8%, compared with 21.9%.
Updated 2026 guidance will be given on the April 23, 2026 earnings call at 8:30 a.m. Eastern Time.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.